CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Pureos Bioventures Expands Team with New Venture Partners

Life Sciences Review Life Sciences Review | Monday, October 04, 2021
Tweet

Pureos Bioventures, a venture capital company that supports private biotech startups developing innovative medicines, has added many venture partners to its team.


FREMONT, CA: Pureos Bioventures, a venture capital company that supports private biotech startups developing innovative medicines, has added many venture partners to its team. So far, the first-time fund has invested in 11 private biotech startups and has USD 205 million under management. The company is also a partner in BaseLaunch, a biotech startup incubator in Basel, Switzerland. Pureos Bioventures' first portfolio firms have already gone public or been taken over.


Dr. Dragan Grabulovski, Ian Metcalfe, and Dr. Roberto Iacone have joined the team as new venture partners as of September 1st. Covagen AG, a Swiss biotech business specializing in bispecific antibodies and antibody alternatives, has Dragan as its CSO and co-founder. In 2014, Covagen was taken over by Cilag GmbH International, a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies. Dragan has been an independent counsellor to biotech startups, a coach at ETH Zurich and Innosuisse (the Swiss Innovation Agency), a board member, and an entrepreneur since 2015.


In 2020, Ian became the CEO of NovaGo Therapeutics. Ian was the Chief Operating Officer of Corlieve Therapeutics before joining NovaGo, which was taken over by uniQure in July 2021. 


Ian formerly worked at Roche and Nestl in various capacities, involving Investor Relations, Business Development/M & M&A, Global Product Strategy, and late-stage Pharma Development. Ian's previous experience includes running his own business, working in Berna Biotech's R&D division, and seeking money for Etna Biotech, a Sicilian startup.


Roberto is the CEO of Alentis Therapeutics and a physician-scientist (MD PhD) who has progressed many assets to the early stages of clinical development. He has extensive experience in rare diseases, fibrosis, immunology, oncology, and translational medicine and strategic planning. Before joining Alentis, Roberto was a leadership team member that took Black Diamond Therapeutics from creation to NASDAQ IPO via various financing rounds. Before that, he was the chief of Roche's rare disease research.


Managing Partners of Pureos Klaus Breiner, Dominik Escher, and Martin Munchbach stated: "We are very pleased to welcome Dragan, Ian and Roberto as our venture partners. They bring tremendous additional experience of building biotech companies to Pureos, which will help the fund to start up and foster our portfolio companies."


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/pureos-bioventures-expands-team-with-new-venture-partners-nwid-585.html